A detailed history of Cetera Investment Advisers transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 6,948 shares of HRMY stock, worth $236,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,948
Previous 7,484 7.16%
Holding current value
$236,648
Previous $225,000 23.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.0 - $39.95 $16,080 - $21,413
-536 Reduced 7.16%
6,948 $277,000
Q2 2024

Aug 22, 2024

SELL
$28.81 - $33.01 $43,877 - $50,274
-1,523 Reduced 16.91%
7,484 $225,000
Q1 2024

May 24, 2024

BUY
$29.93 - $35.06 $269,579 - $315,785
9,007 New
9,007 $302,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.